Helen Morement, DSc (hc), CEO of @CharityAMMF. At the heart of AMMF is #OurCCAFamily – every person diagnosed with #cholangiocarcinoma and their loved ones.
UK
Joined September 2020
- Tweets1.2K
- Following962
- Followers592
- Likes3.6K
Helen Morement retweeted
Second day of the Annual @enscca and @PrecisionBTCnet meeting starts now!
Overview of some of the ongoing projects for each working group
Lots of activity 👏🏻👏🏻
Helen Morement retweeted
Thinking outside the box developing new treatments for BTC at the Annual @enscca and @PrecisionBTCnet meeting
-New compounds
-ADCs
-Niche indications
-Novel technologies
Helen Morement retweeted
Take a look at some of the insights shared from world leading experts highlighted during #AMMF's 2026 European #Cholangiocarcinoma #Conference.
Raising awareness one 💜 at a time.
#bileductcancer #AMMF2026
Helen Morement retweeted
We're launching the Cholangiocarcinoma (CCA) Audit Project - a national audit to better understand how #CCA is managed across the NHS, funded by @CharityAMMF.
Phase one is a survey of hepatobiliary (HPB) units across the UK.
🔗tinyurl.com/yy4r7wst
#Cholangiocarcinoma
ALT Logos associated with the Cholangiocarcinoma audit project - including AMMF - The Cholangiocarcinoma Charity, British Association for the Study of the Liver, Health Data Insight CIC, British Society of Gastroenterology and Cholangiocarcinoma UK
Helen Morement retweeted
Welcome to Day 1 of #AMMF’s European CCA Conference 2026!
Watch on demand day 1 of our patient and carers sessions tomorrow: ammf.org.uk/ammf-conference-…
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
Great to welcome @StuartAndrew MP, Shadow Secretary of State for Health and Social Care to #AMMF's Westminster reception, and to have the opportunity to discuss the challenges faced by those with #cholangiocarcinoma with him!!
Cases of cholangiocarcinoma (bile duct cancer) are rising rapidly, and it has one of the worst survival rates of any cancer. Despite this, only 1-in-3 cholangiocarcinoma patients receive cancer specific treatment. I support @CharityAMMF and their call to #RethinkLiverCancer
All of us at #AMMF send our thanks to the @PereiraAcedoLab for their support for #WorldCCADay 2026, and for all they do to improve our understanding of #cholangiocarcinoma!
#bileductcancer #charityammf
Todays is #WorldCCADay! #CCA is rare but it’s the 2nd most common liver cancer. Help us raise awareness! #RecognizeCCA #Cholangiocarcinoma @WorldCCADay
Helen Morement retweeted
Today, 19 February, is #WorldCCA Day!
To find out more, see: ammf.org.uk/world-cholangioc…
Look out for #AMMF’s posts across social media on World CCA Day, and help raise awareness of #cholangiocarcinoma across the globe by liking and sharing!
#bileductcancer
Helen Morement retweeted
New data suggests that, by 2040, someone will be diagnosed with cancer every two minutes in England. Today we have been in Westminster speaking with #OneCancerVoice, calling on the government to transform cancer outcomes and save lives through an ambitious, fully funded strategy.
ALT A group of more than 30 charity representatives in front of Parliament holding up large colourful jigsaw pieces with cancer statements printed on them
Helen Morement retweeted
🔬Spotlight on Research🔬
Throughout September #AMMF will be showcasing both previously funded and newly funded research projects, this will highlight the importance even small grants can be in kickstarting this critical research.
#bileductcancer #CCA #cholangiocarcinoma
Helen Morement retweeted
🟣SAVE THE DATE🟣
#AMMF is pleased to announce the save the date details of our annual European #Cholangiocarcinoma Conference May 2026.
📅: 13-15 May 2026
📍: Radisson Blu, Stanstead, UK
Further information regarding registration will be provided soon.
#bileductcancer #CCA
Helen Morement retweeted
New survival benchmark for people living with advanced #biliarytractcancer - findings in @jhepatology solidify durvalumab + GemCis as the standard first-line treatment. #cancerresearch #oncology @EASLnews, via @EurekAlert! @elseviernews eurekalert.org/news-releases…
Helen Morement retweeted
A simple blood test for bile duct cancer could be life-changing for people with PSC. We’re funding research to develop one. Hear directly from the experts behind it @JesusMBanales @PMRodrigues19 🗓️ 10 July | ⏰10am | 📍Zoom
➡️ buff.ly/saU4lSd
#LetsBeatPSC @biodonostia
Helen Morement retweeted
📬The Spring 2025 Precision-BTC Newsletter is out!
Catch up on major events, exciting grant updates, new publications, registry progress, and upcoming meetings. This edition is packed with highlights from across the network!
🔗 Read the full edition:precision-btc.eu/newsletters
Helen Morement retweeted
🔬 Upcoming Webinar: Advancing Treatment in BTC
Join us for a new Precision-BTC Network session on:
💡 Hepatic Artery Infusion Pump (HAIP) for BTC
🗓️ Tuesday, July 8 | 🕓 16:00 CET | 📍 Online
🎙 Speakers: Dr Bas Groot Koerkamp & Dr Maeve Lowery
🔗 Zoom: usal-es.zoom.us/j/8284317176…
Helen Morement retweeted
Addenbrooke’s Hospital, Cambridge, has announced that it will be the first in the UK to offer #histotripsy for NHS patients with liver tumours. Learn more about the therapy & the announcement on #AMMF’s website. ammf.org.uk/2025/05/30/histo…
#cholangiocarcinoma #bileductcancer
Helen Morement retweeted
#CCA patient Kevin Wemyss spoke bravely about the disparities in molecular profiling in Scotland on STV
#AMMF are looking forward to discussing ways to #RethinkLiverCancer with @Jenni_Minto at our reception at Holyrood tomorrow.
ow.ly/JjJV50W6iUN
ow.ly/euOf50W6iUO
Helen Morement retweeted
Ongoing clinical trials for #BTC in Europe #COST action webinar series
@PrecisionBTCnet @CcaEns @DrAngelaLamarca
📢New Webinar Series Launch!
Join us for the 1st edition of our new series: Ongoing Clinical Trials for BTC in Europe, hosted by @PrecisionBTCnet (WG3), @CcaEns and UKCCCR.
🗓️4 Sep 2025, 16:00 CET
🎙️Speaker @DrAngelaLamarca
🎤Moderator @LorenzaRimassa
🔗precision-btc.eu/events/webi…
Helen Morement retweeted
#AMMF’s CEO Dr Helen Morement shared data from the Scottish Cancer Registry revealing #CCA rates are higher in Scotland than in England & increased by over 40% from 2001-2018. This highlights the need to #RethinkLiverCancer & get a #FairerDealFaster for CCA patients in Scotland.
